I propose to develop and apply innovative hybrid structural biology tools to investigate the molecular mechanism of signaling through the T cell receptor (TCR) complex. This is a fundamental adaptive immunity pathway through which cytotoxic CD8+ T cells can detect the presence of viruses and developing tumors in the body. Immune function is achieved through the continuous surveillance of antigen-presenting cells for short peptides displayed within the molecules of the Major Histocompatibility Complex (MHC) on the cell surface. Key to the initiation of signaling, is a multi-subunit membrane protein assembly consisting of a clonotypic TCR heterodimer that recognizes the peptide-MHC, together with the invariant CD3 co-receptor hexamer that relays an activation signal from the cell surface intracellularly, through the plasma membrane. Besides the fundamental basic science merit, characterizing this process at atomic detail has important clinical implications, as is suggested by the large number of immunodeficiencies resulting from dysregulation of the signaling components and their interactions. Despite a large number of functional and structural studies, elucidating the 3D structure of the signaling complex as a whole remains extremely challenging by conventional methods, due to its size and dynamic complexity. As a result, the interactions between the TCR and CD3 subunits and the crucial conformational changes needed for signaling remain incompletely characterized. With these bottlenecks in mind, I have developed a new methodology combining datasets from complementary approaches, such as NMR, SANS and cryoEM, together with computational modeling using the program Rosetta to solve the structures of such challenging complexes. Here, I propose to apply this powerful integrative approach to elucidate the T cell receptor complex structure, and to study its dynamic transitions between inactive and active conformations. My immediate goal is to determine the molecular basis of TCR/CD3 interactions and to characterize the crucial structural changes in receptor complex arrangement upon antigen recognition. As a long-term goal, I plan to use a structure-guided approach to engineer novel T cell receptors with custom specificities and signaling properties, to be used in emerging immunotherapy applications.

Public Health Relevance

This application addresses a fundamental process used by our immune T cells to recognize virus-infected cells and tumors that, due to the lack of a detailed structural characterization, lacks a firm understanding of the underlying molecular mechanism. Focusing on the T cell receptor (TCR), I have developed a new technology combining computational modeling methods with complementary experimental datasets for studying protein complexes. I propose to apply this methodology to characterize the complex formed between an established TCR together with its antigen and co-receptor molecules, thereby providing insight into the mechanism of receptor activation and, as a long-term goal of my research program, the knowledge gained from the structural characterization will enable us to engineer new receptor functions to combat viral infections and cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Unknown (R35)
Project #
7R35GM125034-04
Application #
10191789
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Koduri, Sailaja
Project Start
2017-09-01
Project End
2022-08-31
Budget Start
2020-06-01
Budget End
2020-08-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19146
Evangelidis, Thomas; Nerli, Santrupti; Nová?ek, Ji?í et al. (2018) Automated NMR resonance assignments and structure determination using a minimal set of 4D spectra. Nat Commun 9:384
Marcos, Enrique; Chidyausiku, Tamuka M; McShan, Andrew C et al. (2018) De novo design of a non-local ?-sheet protein with high stability and accuracy. Nat Struct Mol Biol 25:1028-1034
Natarajan, Kannan; Jiang, Jiansheng; May, Nathan A et al. (2018) The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling. Front Immunol 9:1657
McShan, Andrew C; Natarajan, Kannan; Kumirov, Vlad K et al. (2018) Peptide exchange on MHC-I by TAPBPR is driven by a negative allostery release cycle. Nat Chem Biol 14:811-820
Toor, Jugmohit S; Rao, Arjun A; McShan, Andrew C et al. (2018) A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations. Front Immunol 9:99
Natarajan, Kannan; McShan, Andrew C; Jiang, Jiansheng et al. (2017) An allosteric site in the T-cell receptor C? domain plays a critical signalling role. Nat Commun 8:15260